title: Immunohistochemistry with keratin, vimentin, desmin, and alpha-smooth muscle actin monoclonal antibodies in canine mammary gland: malignant mammary tumours.
abstract: Ten malignant canine mammary gland tumours and five metastases from three of these tumours were studied immunohistochemically with monoclonal antibodies (MoAbs) directed against different human keratin types (K), alpha-smooth muscle actin, vimentin, and desmin. In all tumours the neoplastic epithelium was rather homogeneously labelled with the keratin MoAbs RCK 102 (K 5 and 8) and CAM 5.2 (K 8). The adenocarcinomas (n = 5), the solid carcinomas (n = 2), and the carcinosarcoma (n = 1) showed heterogeneous labelling with the MoAbs specific for luminal cell antigens in the normal canine mammary gland, i.e., K 18, K 7 and K 19 MoAbs. These cells were also immunoreactive with K 4 and K 10 MoAbs. The spindle cell carcinomas (n = 2), however, did not react with these MoAbs. All tumours except one adenocarcinoma were characterized by the absence of immunoreactive labelling with the alpha-smooth muscle actin MoAb. In the solid carcinomas this was associated with the absence of labelling with one or both basal cell specific keratin MoAbs, i.e., 8.7 (K 14 and 17) and RCK 107 (K 14), respectively. In contrast, the other malignant tumours showed marked labelling of neoplastic epithelium with these MoAbs. Another remarkable finding was the labelling of a limited to moderate number of neoplastic epithelial cells with the vimentin MoAb. The presence of such labelling patterns in canine mammary gland tumours may be indicative of malignancy. Metastatic tumour tissues had a labelling pattern largely similar to that of the primary tumour, although also loss of reactivity for some keratin MoAbs was seen.
authors.affiliation: Department of Pathology, Faculty of Veterinary Medicine, University of Utrecht, The Netherlands.
authors.forename: J H
authors.initials: JH
authors.lastname: Vos
authors.forename: T S
authors.initials: TS
authors.lastname: van den Ingh
authors.forename: W
authors.initials: W
authors.lastname: Misdorp
authors.forename: R F
authors.initials: RF
authors.lastname: Molenbeek
authors.forename: F N
authors.initials: FN
authors.lastname: van Mil
authors.forename: G R
authors.initials: GR
authors.lastname: Rutteman
authors.forename: D
authors.initials: D
authors.lastname: Ivanyi
authors.forename: F C
authors.initials: FC
authors.lastname: Ramaekers
mesh_terms: D000199:Actins / Q000032:analysis* / Q000276:immunology; D000230:Adenocarcinoma / Q000737:chemistry; D000818:Animals; D000911:Antibodies, Monoclonal; D002277:Carcinoma / Q000737:chemistry; D002296:Carcinosarcoma / Q000737:chemistry; D003893:Desmin / Q000032:analysis / Q000276:immunology; D004283:Dog Diseases / Q000473:pathology*; D004285:Dogs; D007124:Immunoenzyme Techniques / Q000662:veterinary; D007381:Intermediate Filament Proteins / Q000032:analysis* / Q000276:immunology; D007633:Keratins / Q000032:analysis / Q000276:immunology; D015674:Mammary Neoplasms, Animal / Q000737:chemistry*; D014746:Vimentin / Q000032:analysis / Q000276:immunology
chemical_list: D000199:Actins; D000911:Antibodies, Monoclonal; D003893:Desmin; D007381:Intermediate Filament Proteins; D014746:Vimentin; D007633:Keratins